14:09:45 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



Carespan Health Inc
Symbol CSPN
Shares Issued 47,282,297
Close 2023-11-06 C$ 0.10
Market Cap C$ 4,728,230
Recent Sedar Documents

Carespan receives holder OK for proposed ChopraX deal

2023-11-07 09:41 ET - News Release

Mr. Rembert de Villa reports

CARESPAN OBTAINS SHAREHOLDER CONSENT TO PROCEED WITH CHOPRAX VENTURE AND ANNOUNCES: (1) PRIVATE PLACEMENT OFFERING; (2) NEW CONTRACT FOR RESERVE AND ACTIVE-DUTY MILITARY MEDICAL ASSESSMENTS; AND (3) APPOINTMENT OF DARRELL MESSERSMITH TO CEO EFFECTIVE JANUARY 1, 2024

Carespan Health Inc., further to its press releases dated Sept. 13, 2023, and Oct. 12 2023, has received the requisite consent from the majority of its shareholders, via written resolution, approving the company's proposed venture with ChopraX LLC to set up a business of integrative care using the Carespan technology platform and operations (the business) and the resulting creation of ChopraX as a new control person (as such term is defined under the policies of the TSX Venture Exchange) of the company, pursuant to the definitive agreement dated Sept. 12, 2023, between the company and ChopraX. The majority shareholder support is intended to satisfy the TSX Venture Exchange condition that the company obtain shareholder approval for the creation of a new control person pursuant to Section 5.14 under Policy 5.3 -- Acquisitions and Dispositions of Non-Cash Assets. The closing of the business remains subject to the satisfaction of various conditions including, among others, the final approval of the TSX-V.

The company thanks its shareholders for their continued support. The consent letters for the business provided by shareholders reaffirm the confidence the company's shareholders have in the ability of the company's board and management team to complete and advance Carespan's proposed venture with ChopraX.

Private placement

The company is pleased to announce the non-brokered private placement offering of units of the company at a price of 10 cents per unit for aggregate gross proceeds of a minimum of $2-million and up to a maximum of $3-million, or such other amounts as determined by the company. Each unit will consist of: (i) one common share of the company; and (ii) one-half of one share purchase warrant of the company whereby a warrant is exercisable for one share at an exercise price of 15 cents per warrant share for a period of five years from the closing date of the offering.

The gross proceeds raised from the offering will be used for the business and general corporate and working capital purposes. The closing of the offering is expected to occur on or prior to January, 2024, and is subject to receipt of all applicable regulatory approvals, including the approval of the TSX-V. Pursuant to the definitive agreement, the closing of the business is subject to the completion of the offering which is taking place concurrently with the business.

Under the offering, the units may be offered to: (i) Canadian residents; (ii) United States residents; and (iii) residents outside of Canada and United States. The underlying securities of the units issued pursuant to the offering will be subject to a statutory hold period of four months and one day from the closing date.

New contract for reserve and active-duty military medical assessments

The company is also pleased to announce that American Advanced Practice Network (American-APN), a Carespan professional corporation, has been awarded an additional contract to conduct assessments for military servicemembers in multiple states and locations across the United States. American-APN providers across the United States use the Carespan Clinic-in-the-Cloud solution to deliver primary, chronic and urgent care to underserved geographies in the United States.

American-APN clinicians will work with servicemembers as part of the Reserve Health Readiness Program. Patients will include current military reservists, active military servicemembers in certain locations and certain civilians covered by the contract. These routine examinations support medical readiness by ensuring that each patient meets the medical standards and requirements to safely and effectively continue their service.

Since 2021, American-APN providers have worked with over 3,000 veterans to assess and document service-related conditions. "Carespan is proud to compassionately support veterans by enabling them to receive the care and compensation they are entitled to," said Rembert de Villa, chairman and chief executive officer of Carespan. "This new contract demonstrates the company's commitment to the wellness of current reservists and active-duty military, as well as Carespan's dedication to helping its member practitioners grow their practices."

Nurse practitioners who are already panelled to complete the veterans' examinations are eligible for training and participation under the contract. At scale, the contract is expected to contribute growth for Carespan and its networks. The contract is a result of the company's strategic pivot to higher-margin services that can yield sustainable growth.

The company experienced a recent decrease in revenue from one of its major nurse practitioner practices. However, the margins from this revenue stream have been relatively low. Carespan and its networks are currently undergoing a strategic structural transformation, focusing on higher-margin services that may yield sustainable and profitable growth.

Nurse practitioners currently in the company's network are eligible to be trained and participate under the contract to conduct military personnel and reservist examinations. The contract is expected to contribute to the company's growth trajectory at scale. Furthermore, the company is actively recruiting and in the process of onboarding several new providers, currently completing their credentialling, to strengthen Carespan's network and capture new revenue.

The contract is aimed at reservists and active-duty military personnel, along with the business, are important elements of the company's strategic pivot. These new revenue initiatives are expected to diversify the company's revenue sources away from other recently decreasing revenue sources of the company, and more importantly, potentially positively contribute to the company's profit margins over time. Carespan is focused on implementing these changes toward building a business with profitable long-term growth to Carespan and its affiliated networks.

Appointment of Darrell Messersmith to CEO

The board of directors of Carespan is also pleased to announce the appointment of Darrell Messersmith as chief executive officer of the company, effective Jan. 1, 2024. Mr. de Villa, current CEO, will continue in his role as director and chairman of the board.

Mr. Messersmith joined Carespan in June, 2022, as head of technology. He was then promoted to head of technology and operations in October, 2022, then to chief operating officer in January, 2023. Mr. de Villa commented, "I could think of no better person to take the helm of Carespan at this time and lead the company to its next level of evolution." He added: "Darrell has proven to be an extremely effective leader and possesses the health care expertise, in-depth experience and strategic thinking needed to drive Carespan's growth going forward. The board is delighted to see that this planned succession will be implemented seamlessly."

"I am honoured to have the mandate from board to lead the growth of Carespan in the coming years," said Mr. Messersmith, incoming CEO of Carespan. "I have always believed in the company's vision of enabling care delivery with leading-edge technology to achieve better health outcomes for patients. That is and will always be my passion."

Mr. Messersmith joined Carespan with more than 25 years of experience in health care system leadership, working with providers and system leadership to advance clinical care and technology adoption. Mr. Messersmith is the former vice-president of information technology, chief information officer and chief medical information officer at Vail Health in Colorado, and prior to that he was chief information officer at Platte Valley Medical Center in the Denver metro area.

Mr. Messersmith began his career as a physical therapist and clinical department leader, and brings a patient-centred and provider's perspective to technology planning and deployment. His move from clinical systems leadership to technology came in 2010 when he was asked to lead large electronic medical record (EMR) implementations and technology projects. Since that time, he has successfully led numerous technology initiatives, including analytics and decision support, revenue cycle, clinical documentation improvement, EMR optimization, interoperability, and information exchange. Mr. Messersmith has a strong history as a trusted adviser and thought leader among his peers.

Mr. Messersmith holds a master of science degree in physical therapy from Andrews University, a bachelor of science in anatomy and physiology, and a bachelor of science in psychology from Walla Walla University. He is a certified health care CIO and completed the Advisory Board Fellowship for health care leaders in 2018.

About Carespan Health Inc.

Carespan is a health care technology and services company that has developed and deployed a unique, proprietary integrated digital care platform, the Carespan Clinic-in-the Cloud, that creates easy access to care for the underserved. With a patient-centric approach focused on improving health outcomes, Carespan uses sophisticated digital tools and capabilities to improve patient outcomes in primary care, chronic care, urgent care and mental health. In addition to the integrated digital care platform, Carespan has built and deployed a business support infrastructure for its professional networks, American-Advanced Practice Network and AmericanMedPsych Network. American-Advanced Practice Network harnesses the clinical capabilities of nurse practitioners to address the shortage in primary and chronic care in the country. AmericanMedPsych brings together providers to tackle shortages mainly in mental health.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.